Business Description
Guangdong Taienkang Pharmaceutical Co Ltd
ISIN : CNE1000058X0
Share Class Description:
SZSE:301263: Class ACompare
Compare
Traded in other countries / regions
301263.China IPO Date
2022-03-29Description
Guangdong Taienkang Pharmaceutical Co Ltd is engaged in the research and development, production, sales of pharmaceutical products, medical equipment, sanitary materials, and provision of medical-technical services and technology transfer.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.29 | |||||
| Equity-to-Asset | 0.78 | |||||
| Debt-to-Equity | 0.15 | |||||
| Debt-to-EBITDA | 1.62 | |||||
| Interest Coverage | 24.76 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 9.5 | |||||
| Beneish M-Score | -2.29 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -8.8 | |||||
| 3-Year EBITDA Growth Rate | -9.9 | |||||
| 3-Year EPS without NRI Growth Rate | -13.6 | |||||
| 3-Year Book Growth Rate | 31.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 60.46 | |||||
| 9-Day RSI | 57.29 | |||||
| 14-Day RSI | 56.9 | |||||
| 6-1 Month Momentum % | 14.82 | |||||
| 12-1 Month Momentum % | -10.55 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.45 | |||||
| Quick Ratio | 3.1 | |||||
| Cash Ratio | 1.73 | |||||
| Days Inventory | 121.01 | |||||
| Days Sales Outstanding | 161.22 | |||||
| Days Payable | 120.67 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.94 | |||||
| Dividend Payout Ratio | 0.84 | |||||
| Forward Dividend Yield % | 1.94 | |||||
| 5-Year Yield-on-Cost % | 1.94 | |||||
| 3-Year Average Share Buyback Ratio | -10.1 | |||||
| Shareholder Yield % | -1.12 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 59.76 | |||||
| Operating Margin % | 22.63 | |||||
| Net Margin % | 17.91 | |||||
| FCF Margin % | -19.85 | |||||
| ROE % | 7.5 | |||||
| ROA % | 6.03 | |||||
| ROIC % | 9.69 | |||||
| ROC (Joel Greenblatt) % | 20.41 | |||||
| ROCE % | 8.16 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 48.31 | |||||
| PE Ratio without NRI | 43.43 | |||||
| Shiller PE Ratio | 53.31 | |||||
| Price-to-Owner-Earnings | 144.29 | |||||
| PEG Ratio | 5.43 | |||||
| PS Ratio | 8.67 | |||||
| PB Ratio | 3.71 | |||||
| Price-to-Tangible-Book | 5.21 | |||||
| Price-to-Operating-Cash-Flow | 227.05 | |||||
| EV-to-EBIT | 38.31 | |||||
| EV-to-EBITDA | 38.31 | |||||
| EV-to-Revenue | 8.12 | |||||
| EV-to-FCF | -40.9 | |||||
| Price-to-Projected-FCF | 3.95 | |||||
| Price-to-Graham-Number | 3.17 | |||||
| Price-to-Net-Current-Asset-Value | 9.85 | |||||
| Price-to-Net-Cash | 81.37 | |||||
| Earnings Yield (Greenblatt) % | 2.61 | |||||
| FCF Yield % | -2.27 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Guangdong Taienkang Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 752.062 | ||
| EPS (TTM) (Â¥) | 0.32 | ||
| Beta | 0 | ||
| Volatility % | 29.8 | ||
| 14-Day RSI | 56.9 | ||
| 14-Day ATR (Â¥) | 0.510552 | ||
| 20-Day SMA (Â¥) | 15.2335 | ||
| 12-1 Month Momentum % | -10.55 | ||
| 52-Week Range (Â¥) | 11.65 - 17 | ||
| Shares Outstanding (Mil) | 425.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Guangdong Taienkang Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Guangdong Taienkang Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Guangdong Taienkang Pharmaceutical Co Ltd Frequently Asked Questions
What is Guangdong Taienkang Pharmaceutical Co Ltd(SZSE:301263)'s stock price today?
The current price of SZSE:301263 is ¥15.46. The 52 week high of SZSE:301263 is ¥17.00 and 52 week low is ¥11.65.
When is next earnings date of Guangdong Taienkang Pharmaceutical Co Ltd(SZSE:301263)?
The next earnings date of Guangdong Taienkang Pharmaceutical Co Ltd(SZSE:301263) is .
Does Guangdong Taienkang Pharmaceutical Co Ltd(SZSE:301263) pay dividends? If so, how much?
The Dividend Yield %  of Guangdong Taienkang Pharmaceutical Co Ltd(SZSE:301263) is 1.94% (As of Today), Highest Dividend Payout Ratio of Guangdong Taienkang Pharmaceutical Co Ltd(SZSE:301263) was 1.94. The lowest was 0.47. And the median was 1.21. The  Forward Dividend Yield % of Guangdong Taienkang Pharmaceutical Co Ltd(SZSE:301263) is 1.94%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers